IDEXX Labs Is Maintained at Hold by Stifel
IDEXX Laboratories Analyst Ratings
Is IDEXX Laboratories Inc. (IDXX) the Best Quality Stock to Buy According to Analysts?
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $500
Express News | IDEXX Laboratories Inc : Stifel Cuts Target Price to $500 From $510
Are Options Traders Betting on a Big Move in IDEXX Laboratories (IDXX) Stock?
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching
IDEXX Laboratories to Release 2024 Third Quarter Financial Results
IDEXX Laboratories (NASDAQ:IDXX) Ticks All The Boxes When It Comes To Earnings Growth
IDEXX Laboratories' (NASDAQ:IDXX) Five-year Earnings Growth Trails the Favorable Shareholder Returns
Could The Market Be Wrong About IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Its Attractive Financial Prospects?
Those Who Invested in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Are up 78%
A Look At The Fair Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
$100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today
$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $550
BofA Securities analyst Michael Ryskin maintains $IDEXX Laboratories Inc(IDXX.US)$ with a hold rating, and maintains the target price at $550.According to TipRanks data, the analyst has a success
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $589
Morgan Stanley analyst Erin Wright maintains $IDEXX Laboratories Inc(IDXX.US)$ with a buy rating, and maintains the target price at $589.According to TipRanks data, the analyst has a success rate of 6
BTIG Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $580
BTIG analyst Mark Massaro maintains $IDEXX Laboratories Inc(IDXX.US)$ with a buy rating, and maintains the target price at $580.According to TipRanks data, the analyst has a success rate of 31.2%
Piper Sandler Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $520